Skip to main content
Erschienen in: Infection 1/2014

01.02.2014 | Clinical and Epidemiological Study

Causes of death in HIV-infected patients from the Cologne–Bonn cohort

verfasst von: K. Ehren, C. Hertenstein, T. Kümmerle, J. J. Vehreschild, J. Fischer, D. Gillor, C. Wyen, C. Lehmann, O. A. Cornely, N. Jung, S. Gravemann, M. Platten, J. C. Wasmuth, J. K. Rockstroh, C. Boesecke, C. Schwarze-Zander, G. Fätkenheuer

Erschienen in: Infection | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Causes of death in human immunodeficiency virus (HIV)-infected subjects have changed in countries with high resources over the last several years. Acquired immunodeficiency syndrome (AIDS)-related diseases have become less prevalent, whereas deaths due to non-AIDS causes are increasing. The aim of the present study was to analyse causes of death in the Cologne–Bonn cohort.

Methods

Causes of death from the Cologne–Bonn cohort between 2004 and 2010 were systematically recorded using the CoDe algorithm (The Coding Causes of Death in HIV Project).

Results

In 3,165 patients followed from 2004 to 2010, 182 deaths occurred (5.7 %, 153 males, 29 females). The median age at the time of death was 47 years (range 24–85 years). The most frequent causes of death were AIDS-defining events (n = 60, 33 %), with non-Hodgkin lymphoma (NHL) (n = 29, 16 %) and infections (n = 20, 11 %) being the leading entities in this category. Non-AIDS malignancies accounted for 16 % (n = 29), non-HIV-related infections for 10 % (n = 18), cardiovascular diseases for 7 % (n = 14), suicide or accident for 4 % (n = 7) and liver diseases for 3 % (n = 5) of deaths (unknown n = 47, 26 %). Although the majority of patients (92.5 %) was on antiretroviral therapy (ART), only 50 % were virologically suppressed (HIV-RNA <50 copies/mL) and 44 % had a decreased CD4+ count (<200/μL) at their last visit before death.

Conclusion

One-third of the causes of death in our cohort between 2004 and 2010 was AIDS-related. Since most of these deaths occur with severe immune suppression, they can possibly be prevented by the early diagnosis and treatment of HIV infection. Care providers must be aware of an increased risk for a broad range of diseases in HIV-infected patients and should apply appropriate preventive measures.
Literatur
1.
Zurück zum Zitat Palella FJ Jr, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43:27–34.PubMedCrossRef Palella FJ Jr, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43:27–34.PubMedCrossRef
2.
Zurück zum Zitat May M, Gompels M, Sabin C. Life expectancy of HIV-1-positive individuals approaches normal conditional on response to antiretroviral therapy: UK Collaborative HIV Cohort Study. J Int AIDS Soc. 2012;15:18078.CrossRefPubMedCentral May M, Gompels M, Sabin C. Life expectancy of HIV-1-positive individuals approaches normal conditional on response to antiretroviral therapy: UK Collaborative HIV Cohort Study. J Int AIDS Soc. 2012;15:18078.CrossRefPubMedCentral
3.
Zurück zum Zitat Nakagawa F, Lodwick RK, Smith CJ, et al. Projected life expectancy of people with HIV according to timing of diagnosis. AIDS. 2012;26:335–43.PubMedCrossRef Nakagawa F, Lodwick RK, Smith CJ, et al. Projected life expectancy of people with HIV according to timing of diagnosis. AIDS. 2012;26:335–43.PubMedCrossRef
4.
Zurück zum Zitat May MT, Ingle SM. Life expectancy of HIV-positive adults: a review. Sex Health. 2011;8:526–33.PubMedCrossRef May MT, Ingle SM. Life expectancy of HIV-positive adults: a review. Sex Health. 2011;8:526–33.PubMedCrossRef
5.
Zurück zum Zitat Robert Koch Institut (RKI). HIV-Infektionen/AIDS: Jahresbericht 2011. Epidemiologisches Bulletin 28/2012. Robert Koch Institut (RKI). HIV-Infektionen/AIDS: Jahresbericht 2011. Epidemiologisches Bulletin 28/2012.
6.
Zurück zum Zitat Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord, Lewden C, Bouteloup V, De Wit S, et al. All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol. 2012;41:433–45.PubMedCrossRef Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord, Lewden C, Bouteloup V, De Wit S, et al. All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol. 2012;41:433–45.PubMedCrossRef
7.
Zurück zum Zitat Helleberg M, Kronborg G, Larsen CS, et al. Causes of death among Danish HIV patients compared with population controls in the period 1995–2008. Infection. 2012;40:627–34.PubMedCrossRef Helleberg M, Kronborg G, Larsen CS, et al. Causes of death among Danish HIV patients compared with population controls in the period 1995–2008. Infection. 2012;40:627–34.PubMedCrossRef
8.
Zurück zum Zitat Neuhaus J, Angus B, Kowalska JD, et al. Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. AIDS. 2010;24:697–706.PubMedCrossRefPubMedCentral Neuhaus J, Angus B, Kowalska JD, et al. Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. AIDS. 2010;24:697–706.PubMedCrossRefPubMedCentral
9.
Zurück zum Zitat Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996–2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010;50:1387–96.CrossRef Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996–2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010;50:1387–96.CrossRef
10.
Zurück zum Zitat Weber R, Ruppik M, Rickenbach M, et al. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med. 2013;14:195–207PubMedCrossRef Weber R, Ruppik M, Rickenbach M, et al. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med. 2013;14:195–207PubMedCrossRef
11.
Zurück zum Zitat Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group, Smith C, Sabin CA, Lundgren JD, et al. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS. 2010;24:1537–48.PubMedCrossRef Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group, Smith C, Sabin CA, Lundgren JD, et al. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS. 2010;24:1537–48.PubMedCrossRef
12.
Zurück zum Zitat Helleberg M, Afzal S, Kronborg G, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis. 2013;56:727–34PubMedCrossRef Helleberg M, Afzal S, Kronborg G, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis. 2013;56:727–34PubMedCrossRef
13.
Zurück zum Zitat Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ. 2009;338:a3172.PubMedCrossRef Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ. 2009;338:a3172.PubMedCrossRef
14.
Zurück zum Zitat Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5:e203.PubMedCrossRefPubMedCentral Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5:e203.PubMedCrossRefPubMedCentral
15.
16.
Zurück zum Zitat Qurishi N, Kreuzberg C, Lüchters G, et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet. 2003;362:1708–13.PubMedCrossRef Qurishi N, Kreuzberg C, Lüchters G, et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet. 2003;362:1708–13.PubMedCrossRef
17.
Zurück zum Zitat Schramm W, Rieger A; Teilnehmende Behandlungseinrichtungen. Morbidity and mortality of patients with haemophilia in Germany—update 2010/2011. Hamostaseologie. 2012;32:S5–11.PubMed Schramm W, Rieger A; Teilnehmende Behandlungseinrichtungen. Morbidity and mortality of patients with haemophilia in Germany—update 2010/2011. Hamostaseologie. 2012;32:S5–11.PubMed
18.
Zurück zum Zitat Kowalska JD, Friis-Møller N, Kirk O, et al. The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology. Epidemiology. 2011;22:516–23.PubMedCrossRef Kowalska JD, Friis-Møller N, Kirk O, et al. The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology. Epidemiology. 2011;22:516–23.PubMedCrossRef
19.
Zurück zum Zitat Lewden C, May T, Rosenthal E, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: the “Mortalité 2000 and 2005” surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr. 2008;48:590–8.PubMedCrossRef Lewden C, May T, Rosenthal E, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: the “Mortalité 2000 and 2005” surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr. 2008;48:590–8.PubMedCrossRef
20.
Zurück zum Zitat Reekie J, Kowalska JD, Karpov I, et al. Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study. PLoS One. 2012;7:e41673.PubMedCrossRefPubMedCentral Reekie J, Kowalska JD, Karpov I, et al. Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study. PLoS One. 2012;7:e41673.PubMedCrossRefPubMedCentral
21.
Zurück zum Zitat Rosenthal E, Pialoux G, Bernard N, et al. Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study). J Viral Hepat. 2007;14:183–8.PubMedCrossRef Rosenthal E, Pialoux G, Bernard N, et al. Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study). J Viral Hepat. 2007;14:183–8.PubMedCrossRef
22.
Zurück zum Zitat Weber R, Sabin CA, Friis-Møller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006;166:1632–41.PubMedCrossRef Weber R, Sabin CA, Friis-Møller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006;166:1632–41.PubMedCrossRef
23.
Zurück zum Zitat Hernando V, Sobrino-Vegas P, Burriel MC, et al. Differences in the causes of death of HIV-positive patients in a cohort study by data sources and coding algorithms. AIDS. 2012;26:1829–34.PubMedCrossRef Hernando V, Sobrino-Vegas P, Burriel MC, et al. Differences in the causes of death of HIV-positive patients in a cohort study by data sources and coding algorithms. AIDS. 2012;26:1829–34.PubMedCrossRef
24.
Zurück zum Zitat Zoufaly A, an der Heiden M, Marcus U, et al. Late presentation for HIV diagnosis and care in Germany. HIV Med. 2012;13:172–81.PubMed Zoufaly A, an der Heiden M, Marcus U, et al. Late presentation for HIV diagnosis and care in Germany. HIV Med. 2012;13:172–81.PubMed
25.
Zurück zum Zitat Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97:425–32.PubMedCrossRef Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97:425–32.PubMedCrossRef
26.
Zurück zum Zitat Simard EP, Pfeiffer RM, Engels EA. Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States. Cancer. 2011;117:1089–96.PubMedCrossRefPubMedCentral Simard EP, Pfeiffer RM, Engels EA. Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States. Cancer. 2011;117:1089–96.PubMedCrossRefPubMedCentral
Metadaten
Titel
Causes of death in HIV-infected patients from the Cologne–Bonn cohort
verfasst von
K. Ehren
C. Hertenstein
T. Kümmerle
J. J. Vehreschild
J. Fischer
D. Gillor
C. Wyen
C. Lehmann
O. A. Cornely
N. Jung
S. Gravemann
M. Platten
J. C. Wasmuth
J. K. Rockstroh
C. Boesecke
C. Schwarze-Zander
G. Fätkenheuer
Publikationsdatum
01.02.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 1/2014
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-013-0535-7

Weitere Artikel der Ausgabe 1/2014

Infection 1/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.